Patients Approval is not access: Pilots’ real test is implementation A medicine can be nationally recommended and still be difficult to access if local systems are not ready to identify, offer, deliver, and monitor it.
News Genpact finds $18tn in trapped AI value Genpact and analyst firm HFS Research recently published a new global study identifying four enterprise debts.
Digital Implementing generative AI: A guide for commercial life scie... In a market saturated with articles highlighting the potential of generative AI, it’s crucial to also understand its limitations.
Digital Why security-first design is the fix to stalling AI pilot to... For AI to be transformative in the pharmaceutical industry, it must be designed with a security-first approach.
News AZ grabs FDA nod for Ultomiris in rare kidney disease IgAN AstraZeneca has staked a claim to the increasingly crowded IgAN market with an accelerated approval from the FDA for Ultomiris, its fifth indication.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.